国家级领军人才、陕西省领军人才

西安交通大学基础医学院院长

中国西部科技创新港转化医学研究院院长

中国免疫学会副理事长

Life Sci/BMC Immunol/Int Immunopharmacol杂志副主编

陕西省免疫健康重点实验室主任

陕西省科技创新团队负责人

西安交通大学首届“青年优秀导师”(全校10人)

2.0拔尖班、强基计划、珠峰计划优秀指导教师

学习与研究经历

2004年9月-2009年1月:博士,移植免疫学,中科院动物所;

2009年2月-2014年1月:博士后,免疫学,美国杜克大学;

2014年2月-2015年8月:Research Associate Senior,免疫学,美国杜克大学;

2015年9月-2016年9月:Research Scientist,免疫学,美国杜克大学;

2016年9月-至今:教授、博导,西安交通大学。

主要业绩

已在Immunity、JCI、Sci Adv、PNAS、CMI、J Immunother Cancer、STTT、J Adv Res、Elife、Plos Genetics、J Immunol等杂志上发表SCI论文50余篇,共被引用1000余次;主编人卫、科学出版社等教材8部,主持国家级等6项教改项目,省级教学成果奖1项,发表7篇教学论文。

在研基金项目

主持国家重点研发计划课题、国家自然科学基金委国际(地区)合作与交流重点项目、面上项目、陕西省创新能力支撑计划、陕西省重点研发计划等项目。

研究方向

研究免疫细胞谱系起源、发育分化及功能调控的分子机制,筛选并研发肿瘤、自身免疫病、免疫缺陷等疾病的免疫治疗靶点、药物和策略,具体包括:

1)免疫细胞发育及免疫重建的调控机制;

2)免疫细胞分化及抗肿瘤的分子机制;

3)自身免疫病的发生机制及治疗靶点;

4)多组学解析免疫力和疾病早期诊断与免疫治疗。

主要业绩

已在 ImmunityJCISci AdvPNASCMIJ Immunother CancerSTTTJ Adv ResElifePlos GeneticsJ Immunol 等杂志发表SCI论文60篇,共被引用1800余次;主编人卫科学出版社教材8部,主持国家级等6项教改项目,荣获省级教学成果奖1项,发表7篇教学论文。

代表性论文

1. Sun, L.; Jiao, A.; Liu, H.; Ding, R.; Yuan, N.; Yang, B.; Zhang, C.; Jia, X.; Wang, G.; Su, Y.; Zhang, D.; Shi, L.; Sun, C.; Zhang, A.; Zhang, L.; Zhang, B., Targeting A Disintegrin and Metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity. Signal Transduct Target Ther 2024, 9(1): 152.

2. Wang, X.; Sun, L.; Yang, B.; Li, W.; Zhang, C.; Yang, X.; Sun, Y.; Shen, X.; Gao, Y.; Ju, B.; Gao, Y.; Liu, D.; Song, J.; Su, Y.; Jiao, A.; Liu, H.; Zhang, L.; He, L.; Lei, L.; Chen, W.; Zhang, B., Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation. J Clin Invest 2023, 133 (20): e166628.

3. Jiao, A.; Zhang, C.; Wang, X.; Sun, L.; Liu, H.; Su, Y.; Lei, L.; Li, W.; Ding, R.; Ding, C.; Dou, M.; Tian, P.; Sun, C.; Yang, X.; Zhang, L.; Zhang, B., Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. J Adv Res 2023, 55: 73-87.

4. Sun, L.; Su, Y.; Jiao, A.; Wang, X.; Zhang, B., T cells in health and disease. Signal Transduct Target Ther 2023, 8 (1): 235.

5. Gao, Y.; Li, W.; Wang, Z.; Zhang, C.; He, Y.; Liu, X.; Tang, K.; Zhang, W.; Long, Q.; Liu, Y.; Zhang, J.; Zhang, B.; Zhang, L., SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis. Cell Mol Immunol 2023, 20 (10): 1232-50.

6. Jiao, A.; Sun, C.; Wang, X.; Lei, L.; Liu, H.; Li, W.; Yang, X.; Zheng, H.; Ding, R.; Zhu, K.; Su, Y.; Zhang, C.; Zhang, L.; Zhang, B., DExD/H-box helicase 9 intrinsically controls CD8(+) T cell-mediated antiviral response through noncanonical mechanisms. Sci Adv 2022, 8 (6): eabk2691.

7. Zhang, C.; Lei, L.; Yang, X.; Ma, K.; Zheng, H.; Su, Y.; Jiao, A.; Wang, X.; Liu, H.; Zou, Y.; Shi, L.; Zhou, X.; Sun, C.; Hou, Y.; Xiao, Z.; Zhang, L.; Zhang, B., Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice. J Immunother Cancer 2021, 9 (10): e002809.

8. Wang, X.; Jiao, A.; Sun, L.; Li, W.; Yang, B.; Su, Y.; Ding, R.; Zhang, C.; Liu, H.; Yang, X.; Sun, C.; Zhang, B., Zinc finger protein Zfp335 controls early T-cell development and survival through β-selection-dependent and -independent mechanisms. Elife 2022, 11: e75508.

9. Liu, J.; Yang, B.; Hu, D.; Yuan, N.; Li, W.; Feng, Z.; Su, Y.; Zhang, D.; Yang, X.; Zhang, B., Lineage Tracking Dissects the Fate of Neonatal iNKT Cells Later in Life. Immunology 2025, Epub ahead of print. doi: 10.1111/imm.13909.

10. Liu, H.; Feng, Z.; Jiao, A.; Lan, L.; Ding, R.; Li, W.; Zheng, H.; Su, Y.; Jia, X.; Zhang, D.; Yang, X.; Zhang, L.; Sun, L.; Zhang, B., The Transcription Factor Zfp335 Promotes Differentiation and Survival of Effector Th1 Cells by Directly Regulating Lmna Expression. J Immunol 2024, 212(11): 1714-21.

11. Yuan, N.; Su, Y.; Gao, Y.; Yang, B.; Zhang, T.; Wang, Q.; Zhang, D.; Shi, L.; Jiao, A.; Lei, L.; Sun, L.; Zhang, B., Med1 controls thymic T-cell migration into lymph node through enhancer-based Foxo1-Klf2 transcription program. Eur J Immunol 2024, 54(10): e2350887.

12. Liu, H.; Wang, X.; Ding, R.; Jiao, A.; Zheng, H.; Zhang, C.; Feng, Z.; Su, Y.; Yang, X.; Lei, L.; Sun, L.; Zhang, L.; Sun, C.; Zhang, B., The Transcription Factor Zfp335 Promotes Differentiation and Persistence of Memory CD8(+) T Cells by Regulating TCF-1. J Immunol 2022, 209 (5): 886-95.

13. Jiao, A.; Liu, H.; Ding, R.; Zheng, H.; Zhang, C.; Feng, Z.; Lei, L.; Wang, X.; Su, Y.; Yang, X.; Sun, C.; Zhang, L.; Bai, L.; Sun, L.; Zhang, B., Med1 Controls Effector CD8(+) T Cell Differentiation and Survival through C/EBPβ-Mediated Transcriptional Control of T-bet. J Immunol 2022, 209 (5): 855-63.

14. Zhang, B.; Liu, S. Q.; Li, C.; Lykken, E.; Jiang, S.; Wong, E.; Gong, Z.; Tao, Z.; Zhu, B.; Wan, Y.; Li, Q. J., MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species Equilibrium. Immunity 2016, 44 (3): 568-81.

15. Zhang, B.; Jia, Q.; Bock, C.; Chen, G.; Yu, H.; Ni, Q.; Wan, Y.; Li, Q.; Zhuang, Y., Glimpse of natural selection of long-lived T-cell clones in healthy life. Proc Natl Acad Sci U S A 2016, 113 (35): 9858-63.

16. Zhang, B.; Jiao, A.; Dai, M.; Wiest, D. L.; Zhuang, Y., Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity. J Immunol 2018, 201 (5): 1452-9.

17. Zhang, B.; Wu, J.; Jiao, Y.; Bock, C.; Dai, M.; Chen, B.; Chao, N.; Zhang, W.; Zhuang, Y., Differential Requirements of TCR Signaling in Homeostatic Maintenance and Function of Dendritic Epidermal T Cells. J Immunol 2015, 195 (9): 4282-91.

18. Zhang, B.; Lin, Y. Y.; Dai, M.; Zhuang, Y., Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells. J Immunol 2014, 192 (3): 1055-63.

19. Liu, J.; Zhang, H.; Su, Y.; Zhang, B., Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases. Cell Biosci 2022, 12 (1): 68.

20. Yang, X.; Wang, X.; Lei, L.; Su, Y.; Zou, Y.; Liu, H.; Jiao, A.; Zhang, C.; Liu, J.; Li, W.; Ding, R.; Zhou, X.; Shi, L.; Zhang, D.; Sun, C.; Zhang, B., Arid1a promotes thymocyte development through β-selection-dependent and β-selection-independent mechanisms. Immunology 2022, 165 (4): 402-13.

 

已公开发表全部SCI论文的链接(PubMed):

https://pubmed.ncbi.nlm.nih.gov/?term=baojun+zhang%2C+xi%27an+jiaotong+university

https://pubmed.ncbi.nlm.nih.gov/?term=baojun+zhang%2C+duke+university&sort=date

团队建设:

T细胞生物学(TCB)研究团队,包括教授1名、副教授6名、博士后6名、研究生10名。团队由国家领军人才领衔,团结协作,尊重个性,秉承个人成才与团队发展同频共振的理念,开展基础原创课题研究,解决生命医学科学难题和临床疾病问题。

欢迎副教授、博士后、研究生加入TCB研究团队!

欢迎研究生报考TCB研究团队!

电子邮箱bj.zhang@mail.xjtu.edu.cn

联系电话:029-8265 6681189 9190 6676

个人主页:https://gr.xjtu.edu.cn/en/web/bj.zhang/home

联系地址:雁塔西路76号交大医学部微免楼